-
1
-
-
33645004304
-
Tuberculosis in sub-Saharan Africa: Opportunities, challenges, and change in the of antiretroviral treatment
-
Corbett EI, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the of antiretroviral treatment. Lancet 2006; 367: 926-37.
-
(2006)
Lancet
, vol.367
, pp. 926-937
-
-
Corbett, E.I.1
Marston, B.2
Churchyard, G.J.3
De Cock, K.M.4
-
3
-
-
33644991496
-
Global epidemiology of tuberculosis
-
Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938-40.
-
(2006)
Lancet
, vol.367
, pp. 938-940
-
-
Dye, C.1
-
4
-
-
33645012550
-
Progress towards improved tuberculosis diagnostics for developing countries
-
Perkins MD, Roscigno G, Zumla A. Progress towards improved tuberculosis diagnostics for developing countries. Lancet 2006; 367: 942-3.
-
(2006)
Lancet
, vol.367
, pp. 942-943
-
-
Perkins, M.D.1
Roscigno, G.2
Zumla, A.3
-
5
-
-
18244387427
-
Expanding tuberculosis case detection by screening households contacts
-
Becerra MC, Pachao-Torreblanca I, Bayona J, et al. Expanding tuberculosis case detection by screening households contacts. Publ Health Rep 2005; 120: 271-7.
-
(2005)
Publ Health Rep
, vol.120
, pp. 271-277
-
-
Becerra, M.C.1
Pachao-Torreblanca, I.2
Bayona, J.3
-
6
-
-
33644991999
-
Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings
-
Harries AD, Chimzizi R, Zachariah R. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet 2006; 367: 944-5.
-
(2006)
Lancet
, vol.367
, pp. 944-945
-
-
Harries, A.D.1
Chimzizi, R.2
Zachariah, R.3
-
7
-
-
16644366259
-
Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis
-
Pedral-Sampaio DB, Alves CR, Netto EM, et al. Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis. Braz J Infect Dis 2004; 8: 211-6.
-
(2004)
Braz J Infect Dis
, vol.8
, pp. 211-216
-
-
Pedral-Sampaio, D.B.1
Alves, C.R.2
Netto, E.M.3
-
8
-
-
33645003112
-
Priorities in tuberculosis research
-
Onyebujoh P, Rodriguez W, Mwaba P. Priorities in tuberculosis research. Lancet 2006; 367: 940-1.
-
(2006)
Lancet
, vol.367
, pp. 940-941
-
-
Onyebujoh, P.1
Rodriguez, W.2
Mwaba, P.3
-
9
-
-
33645001016
-
Tuberculosis drug development pipelines: Progress and hope
-
Spigelman M, Gillespie S. Tuberculosis drug development pipelines: progress and hope. Lancet 2006; 367: 945-7.
-
(2006)
Lancet
, vol.367
, pp. 945-947
-
-
Spigelman, M.1
Gillespie, S.2
-
10
-
-
33645008275
-
Progress and hindrances in tuberculosis vaccine development
-
Doherty TM, Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet 2006; 367: 947-9.
-
(2006)
Lancet
, vol.367
, pp. 947-949
-
-
Doherty, T.M.1
Rook, G.2
-
11
-
-
33645016204
-
WHO'S new stop TB strategy
-
Raviglione MC, Uplekar MW. WHO'S new stop TB strategy. Lancet 2006; 367: 952-5
-
(2006)
Lancet
, vol.367
, pp. 952-955
-
-
Raviglione, M.C.1
Uplekar, M.W.2
-
12
-
-
33645002198
-
The Global plan to stop TB: A unique opportunity to address poverty and the Millenium development goals
-
Squire SB, Obasi A, Nhlema-Simwaka B. The Global plan to stop TB: a unique opportunity to address poverty and the Millenium development goals. Lancet 2006; 367: 955-7.
-
(2006)
Lancet
, vol.367
, pp. 955-957
-
-
Squire, S.B.1
Obasi, A.2
Nhlema-Simwaka, B.3
|